Cetera Investment Advisers Has $33.01 Million Holdings in Colgate-Palmolive Company $CL

Cetera Investment Advisers raised its position in shares of Colgate-Palmolive Company (NYSE:CLFree Report) by 27.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 387,355 shares of the company’s stock after buying an additional 82,255 shares during the period. Cetera Investment Advisers’ holdings in Colgate-Palmolive were worth $33,014,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Envision Financial Transparency LLC purchased a new position in shares of Colgate-Palmolive in the first quarter worth approximately $338,000. First Citizens Bank & Trust Co. raised its holdings in shares of Colgate-Palmolive by 4.5% during the first quarter. First Citizens Bank & Trust Co. now owns 13,483 shares of the company’s stock valued at $1,149,000 after acquiring an additional 581 shares during the period. ABN Amro Investment Solutions lifted its position in shares of Colgate-Palmolive by 7.9% in the 1st quarter. ABN Amro Investment Solutions now owns 140,942 shares of the company’s stock valued at $12,012,000 after acquiring an additional 10,264 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Colgate-Palmolive by 1.0% in the 1st quarter. PNC Financial Services Group Inc. now owns 899,670 shares of the company’s stock valued at $76,679,000 after acquiring an additional 9,279 shares in the last quarter. Finally, HORAN Wealth LLC boosted its stake in Colgate-Palmolive by 108.7% in the 1st quarter. HORAN Wealth LLC now owns 9,308 shares of the company’s stock worth $742,000 after purchasing an additional 4,849 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have weighed in on CL shares. Rothschild & Co Redburn set a $100.00 price objective on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research report on Tuesday, April 21st. Barclays increased their target price on Colgate-Palmolive from $80.00 to $87.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Bank of America decreased their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Wells Fargo & Company upped their price target on Colgate-Palmolive from $92.00 to $95.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 8th. Twelve equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $97.82.

Check Out Our Latest Stock Analysis on CL

Colgate-Palmolive Trading Up 0.7%

NYSE CL opened at $90.74 on Friday. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The firm’s fifty day simple moving average is $90.77 and its 200-day simple moving average is $88.96. The company has a market capitalization of $72.61 billion, a PE ratio of 35.31, a price-to-earnings-growth ratio of 4.78 and a beta of 0.33.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same quarter last year, the firm earned $0.91 earnings per share. The business’s revenue for the quarter was up 8.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s payout ratio is currently 82.49%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.